.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Baxter
Fish and Richardson
Colorcon
Merck
Cerilliant
Moodys
Teva
Harvard Business School

Generated: November 22, 2017

DrugPatentWatch Database Preview

Nesher Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for NESHER PHARMS, and what generic and branded alternatives to NESHER PHARMS drugs are available?

NESHER PHARMS has thirty-three approved drugs.

There is one tentative approval on NESHER PHARMS drugs.

Summary for Nesher Pharms

US Patents:0
Tradenames:22
Ingredients:20
NDAs:33
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms
HYDROMORPHONE HYDROCHLORIDE
hydromorphone hydrochloride
TABLET;ORAL077311-002Nov 9, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
OSELTAMIVIR PHOSPHATE
oseltamivir phosphate
CAPSULE;ORAL208578-002Feb 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
OSELTAMIVIR PHOSPHATE
oseltamivir phosphate
CAPSULE;ORAL208578-001Feb 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL077290-003Dec 8, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
HYDROMORPHONE HYDROCHLORIDE
hydromorphone hydrochloride
TABLET;ORAL077311-001Nov 9, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION;ORAL076982-001May 24, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
OSELTAMIVIR PHOSPHATE
oseltamivir phosphate
CAPSULE;ORAL208578-003Feb 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL209111-001Jun 27, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL209111-003Jun 27, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
BENZONATATE
benzonatate
CAPSULE;ORAL040795-001Oct 31, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Nesher Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Nesher Pharms
MICRO-K
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL018238-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Nesher Pharms
MICRO-K 10
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL018238-002May 14, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Cipla
Citi
Cantor Fitzgerald
Mallinckrodt
Medtronic
Daiichi Sankyo
Deloitte
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot